european coagulation diagnostics markets frost sullivan

European Coagulation Diagnostics Markets – Frost & Sullivan

This strategic analysis service provides a detailed analysis of the European coagulation market. An indepth analysis of marketing parameters (revenues, forecasts, geographic trends and market share) coupled with competitive factors and strategies for sustained market prevalence are reported.,Frost & Sullivan: European HIV Diagnostics Manufacturers … ,LONDON, Feb. 20, 2013 /PRNewswire/ — Frost & Sullivan: European HIV Diagnostics Manufacturers Need to Target Large, Undiagnosed HIV Population,SCIP :: European Coagulation Diagnostics Markets ,European Coagulation Diagnostics Markets This strategic analysis service provides a detailed analysis of the European coagulation market. An indepth analysis of marketing parameters (revenues, forecasts, geographic trends and market share) coupled with competitive factors and strategies for sustained market prevalence are reported.

Frost & Sullivan Presents Market Penetration Leadership …

LONDON, February 16 /PRNewswire/ — France-based Diagnostica Stago has been conferred the 2005 Frost & Sullivan Market Penetration Leadership Award for its excellence in capturing market share within the European coagulation diagnostics arena.,Frost & Sullivan: European HIV diagnostics manufacturers … ,Over 32% of HIV+ people in Europe remain undiagnosed. This large untapped pool and the development of novel nucleic acid test (NAT) and non-NAT technology based platforms offers growth potential f …,In-vitro Diagnostics (IVD) Market … – Frost & Sullivan ,This research service analyses the IVD in China, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and forecast the same till 2017.

Expanding High Risk Population Drives European Hepatitis B …

— Expanding High Risk Population Drives European Hepatitis B and C Diagnostics Market, finds Frost & Sullivan,Expanding high risk population drives European hepatitis B … ,In recent years, the prevalence of hepatitis C has increased among high risk sub-group populations, including immigrants from areas where the disease is endemic, injecting drug users (IDUs) and pa …,Frost & Sullivan predicts growth for the infectious … ,Frost & Sullivan predicts growth for the infectious disease diagnostics market The infectious disease diagnostics market is driven by unprecedented outbreaks of infections and rising awareness of people and policy makers towards the vital use of diagnostic tools to control widespread outbreaks.

European Coagulation Diagnostics Markets – Frost & Sullivan

This strategic analysis service provides a detailed analysis of the European coagulation market. An indepth analysis of marketing parameters (revenues, forecasts, geographic trends and market share) coupled with competitive factors and strategies for sustained market prevalence are reported.,SCIP :: European Coagulation Diagnostics Markets ,European Coagulation Diagnostics Markets This strategic analysis service provides a detailed analysis of the European coagulation market. An indepth analysis of marketing parameters (revenues, forecasts, geographic trends and market share) coupled with competitive factors and strategies for sustained market prevalence are reported.,Frost & Sullivan: European HIV Diagnostics Manufacturers … ,LONDON, Feb. 20, 2013 /PRNewswire/ — Frost & Sullivan: European HIV Diagnostics Manufacturers Need to Target Large, Undiagnosed HIV Population

Frost & Sullivan: Novel Diagnostics Methods Driving the …

Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention – read this article along with other careers information, tips and advice on BioSpace,European CTI Markets – store.frost.com ,Frost and Sullivan helping clients achieve transformational growth in an economic environment by accelerating change and increasing the conversion of new business models and mega trends on their industry.,Frost & Sullivan: European HIV diagnostics manufacturers … ,Over 32% of HIV+ people in Europe remain undiagnosed. This large untapped pool and the development of novel nucleic acid test (NAT) and non-NAT technology based platforms offers growth potential f …

Frost & Sullivan: European HIV Diagnostics Manufacturers …

/PRNewswire/ — Over 32% of HIV+ people in Europe remain undiagnosed. This large untapped pool and the development of novel nucleic acid test (NAT) and non-NAT…,Frost & Sullivan Presents Market Penetration Leadership … ,LONDON, February 16 /PRNewswire/ — France-based Diagnostica Stago has been conferred the 2005 Frost & Sullivan Market Penetration Leadership Award for its excellence in capturing market share within the European coagulation diagnostics arena.,Frost & Sullivan: European HIV Diagnostics Manufacturers … ,), Analysis of European HIV Diagnostics Market, finds that the market is estimated to expand from $797.1 million in 2012 to approximately $1,164.4 million in 2019. The research covers HIV NAT diagnostics and immunodiagnostics.

Frost & Sullivan: European HIV Diagnostics Manufacturers …

Over 32% of HIV+ people in Europe remain undiagnosed. This large untapped pool and the development of novel nucleic acid test (NAT) and non-NAT technology based platforms offers growth,Frost & Sullivan: European HIV Diagnostics Manufacturers … ,/PRNewswire/ — Over 32% of HIV+ people in Europe remain undiagnosed. This large untapped pool and the development of novel nucleic acid test (NAT) and non-NAT…,Expanding High Risk Population Drives European Hepatitis B … ,/PRNewswire/ — In recent years, the prevalence of hepatitis C has increased among high risk sub-group populations, including immigrants from areas where the…

Frost & Sullivan – Diagnostics Market Research Reports …

Diagnostics market research reports by Frost & Sullivan. Filter your search. Refine your search (114 reports matching your criteria),Frost & Sullivan – Molecular Diagnostics Market Research … ,Molecular Diagnostics market research reports by Frost & Sullivan. Refine your search (9 reports matching your criteria). Refine your search ×,Expanding High Risk Population Drives European Hepatitis B … ,New analysis from Frost & Sullivan (lifesciences.frost.com), Analysis of the European Hepatitis B and C Diagnostics Market, estimates revenues of the hepatitis B diagnostics to grow from $165.9 million in 2012 to $260.2 million in 2019 and hepatitis C diagnostics market to grow from $3,140.8 million in 2012 to $4,940.9 million in 2019 …

POCT brings values • healthcare-in-europe.com

Frost and Sullivan (F&S) a consultancy with strong focus on growing markets, published a 158-page market analysis in 2010 (on revenues from €1.87 billion and 8.2% growth rate in 2009, the analysts calculate the potential revenues –maximum future market size – of €3.89 billion, with a compound annual growth rate of 10.9% (pic. 2).,Global In Vitro Diagnostics Market Outlook, 2021 ,The top-10 companies serving the IVD industry together accounted for 65.2% of the global revenue in 2020, while the top-20 companies together made up 78.8% of the global proceeds. The NA region, primarily with contributions from the US, leads the market, maintaining its stronghold on the IVD industry.,In Vitro Diagnostics Market Size & Growth Report, 2021-2027 ,Report Overview. The global in vitro diagnostics market size was valued at USD 83.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2027.

Frost & Sullivan: European HIV Diagnostics Manufacturers …

Over 32% of HIV+ people in Europe remain undiagnosed. This large untapped pool and the development of novel nucleic acid test (NAT) and non-NAT technology based platforms offers growth,Frost Sullivan: Novel Diagnostics Methods Driving The … ,Frost Sullivan: Novel Diagnostics Methods Driving The European Cancer IVD Market Towards Early Detection And Prevention. By Anna Ohlden | February 24th 2009 03:00 AM | Print | E-mail.,Frost & Sullivan: Novel Diagnostics Methods Driving the … ,Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention – read this article along with other careers information, tips and advice on BioSpace

Frost & Sullivan: European HIV Diagnostics Manufacturers …

), Analysis of European HIV Diagnostics Market, finds that the market is estimated to expand from $797.1 million in 2012 to approximately $1,164.4 million in 2019. The research covers HIV NAT diagnostics and immunodiagnostics.,Frost & Sullivan: European HIV Diagnostics Manufacturers … ,/PRNewswire/ — Over 32% of HIV+ people in Europe remain undiagnosed. This large untapped pool and the development of novel nucleic acid test (NAT) and non-NAT…,Frost & Sullivan – Molecular Diagnostics Market Research … ,Molecular Diagnostics market research reports by Frost & Sullivan. Refine your search (9 reports matching your criteria). Refine your search ×

Frost & Sullivan – Diagnostics Market Research Reports …

Diagnostics market research reports by Frost & Sullivan. Filter your search. Refine your search (114 reports matching your criteria),Growth Opportunities in the Western European Oncology … ,The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast cancer, ovarian cancer, cervical cancer …,POCT brings values • healthcare-in-europe.com ,Frost and Sullivan (F&S) a consultancy with strong focus on growing markets, published a 158-page market analysis in 2010 (on revenues from €1.87 billion and 8.2% growth rate in 2009, the analysts calculate the potential revenues –maximum future market size – of €3.89 billion, with a compound annual growth rate of 10.9% (pic. 2).